ADPT Adaptive Biotechnologies Corp: Forvard P/S multiplikatori
Adaptive Biotechnologies joriy GURU.Markets platformasi grafigidagi prognoz qilingan P/S ko'rsatkichi bilan tasdiqlanganidek, yuqori aniqlikdagi avtomatlashtirilgan immun xaritalash laboratoriyalariga tayanadi, bunda joriy raqam 16.00 ni tashkil etadi. Kompaniya maqsadli terapiyalarni ishlab chiqish uchun T-hujayra retseptorlarini sekvensirlashda yetakchilikka intilmoqda. Onkologiyadagi minimal qoldiq kasalliklarini monitoring qilish tizimlari, tadqiqot va ishlanmalarga katta investitsiyalar kiritilganiga qaramay, barqaror o'sishni ta'minlaydi.
Adaptive Biotechnologies Inc. (ADPT) moliyaviy va bozor koʻrsatkichlari kesimi
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- emitentning balans qiymati statistikasi:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Qarzning xususiy kapitalga nisbati Adaptive Biotechnologies|ADPT - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Adaptive Biotechnologies|ADPT - Kompaniyaning yig'indi qarzdorligi|Balans kapitallashuviga qarzlar Adaptive Biotechnologies Inc.|ADPT - Uzoq muddatli qarz hajmi|Kompaniyaning qisqa muddatli majburiyatlari Adaptive Biotechnologies|Tezkor likvidlik koeffitsiyenti adaptivebiotech.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
ADPT - Kompaniyaning sof daromadi|Kelajakdagi foyda Adaptive Biotechnologies|ADPT - Kompaniya qiymatining sof foydaga nisbati|Forvard P/E multiplikatori Adaptive Biotechnologies Corp|ADPT - Narxning foydaga va o‘sish sur’atiga nisbati|EV/EBITDA multiplikatori Adaptive Biotechnologies Inc.|ADPT - Amortizatsiya chegirilmasdan oldingi operatsion daromad|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Adaptive Biotechnologies|ADPT - So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi adaptivebiotech.com|ADPT - Joriy yil uchun bitta aksiya uchun sof foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Adaptive Biotechnologies
- sotuvlar va tushum ko'rsatkichlari:
Kompaniyaning umumiy tahlili:Adaptive Biotechnologies Corporation ADPT
AI tomonidan boshqariladigan immun xaritalashning murakkabligi va patent himoyasi Adaptive Biotechnologies (ADPT) kompaniyasining yuqori biznes baholashini ta'minlaydi. Emitentning forward P/S koeffitsiyentini tahlil qilish orqali investorlar bozor kapitalizatsiyasini kutilayotgan daromadlar bilan solishtiradilar, bu esa ularga texnologik yetakchilik uchun to'langan premiumni aniqlash yoki qat'iy FDA tartibga solishlari va biomeditsina grantlariga bog'liqlik fonida yashirin baholash zaifliklarini aniqlash imkonini beradi.
Raqobatdosh kompaniyalar tahlili
Forvard P/S multiplikatori ARGX (argenx)|BioNTech Inc. (BNTX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Abivax Corp - Forvard P/S multiplikatori|ADMA - Forvard P/S multiplikatori|PTGX: Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati IMVT|KNSA (Kiniksa) - Forvard P/S multiplikatori|Forvard P/S multiplikatori Grifols SA|Narxning prognoz qilingan daromadga nisbati Celldex (CLDX)|AUPH: Kelajakdagi narxning daromadga nisbati|BioCryst - Forvard narx/daromad multiplikatori|Narxning kutilayotgan daromadga nisbati VERA (veratx.com)|Dianthus Therapeutics, Inc. - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Pharvaris NV PHVS|ABCL (AbCellera Biologics Inc) - Forvard narx/daromad multiplikatori|TRML (Tourmaline) - Narxning prognoz qilingan daromadga nisbati|PGEN (Precigen, Inc.) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati pharming.com PHAR|Forvard narx/daromad multiplikatori NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio, Inc.) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori ZBIO (Zenas Biopharma, Inc.)|Immunome Bio - Narxning prognoz qilingan daromadga nisbati|Gossamer Bio, Inc. - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati kalvista.com KALV|Septerna (SEPN) - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Pieris Pharma (PVLA)|Forvard narx/daromad multiplikatori SVRA|RIGL (Rigel Corp) - Narxning kutilayotgan daromadga nisbati|Forvard P/S multiplikatori ANAB|ATXS - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Forvard P/S multiplikatori ENGN (enGene)|RAPT - Forvard narx/daromad multiplikatori|Aerovate - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx ACRS (Aclaris Therapeutics, Inc)|Kyverna Therapeutics (KYTX) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati TLSA|Narxning prognoz qilingan daromadga nisbati Cabaletta Bio|Bozor kapitallashuvining kelajakdagi daromadga nisbati Ventyx Biosciences Inc. VTYX|Narxning prognoz qilingan daromadga nisbati Theratechnologies Inc (THTX)|Narxning prognoz qilingan daromadga nisbati AVTX (Avalo Therapeutics Inc)|Narxning prognoz qilingan daromadga nisbati Eledon Pharmaceuticals ELDN|agenusbio.com (AGEN) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Climb Bio - Forvard P/S multiplikatori|Prognoz narxning daromadga nisbati Zura Bio Ltd (ZURA)|ATYR: Forvard P/S multiplikatori|ADAG - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|IMA (ImageneBio) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Shattuck Therapeutics STTK|Narxning prognoz qilingan daromadga nisbati Equillium, Inc. (EQ)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati connectbiopharm.com|Forvard P/S multiplikatori IMUX (Immunic)|Forvard P/S multiplikatori Atara Biotherapeutics, Inc. ATRA|InflaRx GmbH - Forvard P/S multiplikatori|XFOR (x4pharma.com) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|adicetbio.com (ACET) - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati CELU (Celularity)|Forvard narx/daromad multiplikatori INMB|BRNS (Barinthus Biotherapeutics Corp) - Narxning kutilayotgan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Kezar Life Sciences (KZR)|SABS: Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori AKTX (Akari Therapeutics Plc)|Sotuvga nisbatan forvard narx ENLV|Q32 Bio Corp - Forvard P/S multiplikatori|GOVX - Forvard P/S multiplikatori|Edesa Biotech, Inc. (EDSA) - Narxning prognoz qilingan daromadga nisbati|ibioinc.com - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Carisma Therapeutics Inc|Forvard narx/daromad multiplikatori XTL Biopharmaceuticals Ltd (XTLB)|Forvard P/S multiplikatori BOLT|Forvard P/S multiplikatori hcwbiologics.com (HCWB)|Aptevo Therapeutics Inc. - Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx AIM|Aditxt Corp - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati GRI Bio Inc GRI|XORTX (XRTX) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori Vyome Therapeutics|Narxning prognoz qilingan daromadga nisbati Revelation Biosciences|Forvard narx/daromad multiplikatori indaptusrx.com (INDP)|Forvard narx/daromad multiplikatori SCNI (Scinai Immunotherapeutics Ltd.)|Forvard P/S multiplikatori calcimedica.com (CALI)|Narxning prognoz qilingan daromadga nisbati Affimed N.V. AFMD|ALLK: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|HOOKIPA - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati IGM Biosciences, Inc.|ITOS: Forvard P/S multiplikatori|Ocean Biomedical Inc (OCEA) - Forvard P/S multiplikatori|TCBP (TC BioPharm (Holdings) PLC) - Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati THRD (Third Harmonic Bio Inc)
